Evidence map›Paper›PMID 34046130›Full record

ReviewThe Pan African medical journal2021

What would be the impact of COVID-19 on liver function of a patient with chronic hepatitis B? About a case and literature review.

Khoury M'bodj, Hakima Abid, Najdi Adil, Mohammed El Abkari, Nourdin Aqodad

Open access · goldAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Khoury M'bodjFaculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University, Laboratory of Human Pathology, Biomedicine and Environment, Fez, Morocco.
Hakima AbidFaculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University, Hassan II University Hospital Center, Fez, Morocco.
Najdi AdilFaculty of Medicine and Pharmacy of Tangier, Abdelmalek Essaâdi University, Tangier, Morocco.
Mohammed El AbkariFaculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University, Hassan II University Hospital Center, Fez, Morocco.
Nourdin AqodadFaculty of Medicine and Pharmacy of Agadir, IBN ZOHR University, Hassan II Hospital, Agadir, Morocco.
Abdelmalek Essaâdi University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver damage during COVID-19 disease has been described in numerous studies. Its mechanism is poorly understood. It is mainly reserved for severe forms and is manifested by abnormalities of the hepatic assessment and more particularly cytolysis. Particular attention must be paid to patients with chronic liver disease, both in terms of follow-up and treatment. We wanted to know the evolution of COVID-19 and its treatment, on the liver function of a 27-year-old patient followed for chronic non-cirrhotic hepatitis B at the Hassan II University Hospital in Fez. Our patient had stopped the antiviral B treatment and presented COVID-19 infection with minimal to moderate impairment. The initial evaluation showed cytolysis at 4 times upper limit of normal (ULN). Management consisted in the immediate resumption of Tenofovir in combination with hydroxychloroquine (HCQ) and azythromycin with good clinical and biological evolution.

Indexed as

AdultAntiviral AgentsAzithromycinCOVID-19COVID-19 Drug TreatmentHepatitis B, ChronicHospitals, UniversityHumansHydroxychloroquineLiver Function TestsMaleMoroccoTenofovirAntiviral AgentsAzithromycinHydroxychloroquineTenofovircase reporthepatitis Bliver functionSARS-CoV-2

Identifiers

PMID34046130
PMCPMC8140681
OpenAlexW3134968500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.